Kibow specializes in the development and commercialization of innovative probiotic/prebiotic dietary supplements for kidney health and general wellness to help promote a healthy kidney function for veterinary and human applications. Kibow has two scientifically formulated and clinically validated products on the market: Azodyl®, for cats and dogs with moderate to severe kidney failure (licensed exclusively to Vetoquinol SA, Paris (VETO: EN) since July 2006) and Renadyl™, for humans which has been, proven and tested in clinical studies, to stabilize and/or reduce uremic toxins. Since 2010 Renadyl’s™ unique “enteric toxin reduction” formulation has been marketed via on-line sales and has steadily gained recognition and acceptance among many healthcare providers and kidney failure patients internationally. The technology is based on balancing and stabilization of the “Gut Microbiome” with our proprietary formulation of pro and prebiotics.  Kibow has a registered USPTO trade mark Enteric Dialysis® and 23 approved patents internationally.

Renadyl™ – For Chronic Kidney Disease suitable for all stages and those awaiting kidney transplants

Kibow Flora™ – A multistrain highly specific formulation for boosting intestinal and immune health, particularly, beneficial for the ageing consumer

Kibow Fortis® – A multifiber pro and prebiotic product for natural general wellness, digestive and immune health, satiety and weight management; A single formulation that offers multiple benefits by comparison with most major well-known brands on the pharmacy shelves

Learn More

November 26, 2018

Kibow_landing page image.png.medium.800x800.pngThis whitepaper commentary is primarily aimed at independently updating the recent scientific progress, understanding, and knowledge gained on the emerging concept of “Enteric

Read More
August 16, 2018

[In conjunction with standard care of therapy]

Kibow logo_JPEG.jpg.small.400x400.jpeg

With the recent gains in research and scientific findings, “Enteric Dialysis®” is transforming from concept to a definite reality. It has the potential to provide a promising future for

Read More
May 17, 2018



In 1996, the question originated from Dr. Eli A Friedman’s article, “can the Bowel act as a kidney substitute in advance renal failure?” prior to the discovery of the gut microbiome. The bowel was recognized as an organ in

Read More
April 17, 2018

Kibow-logo_JPEG.jpg.large.1024x1024.jpegThis article reports the results of a short survey given to 600 Renadyl customers to ascertain how their GFR changed and the impact on their quality of life (QoL) after adding the dietary supplement Renadyl™ into their standard care of therapy

Read More
May 10, 2017

On-demand Webinar | Free


We know a lot more now regarding the 23,000 human genes and also the 3.3 million genes coded by our gut microbiome. This webinar discusses the roles and interactions of all of these genes (genomics), their products

Read More
May 9, 2017

gut-graphicDON’T MISS  the whitepaper: “What’s Your Gut Feeling? The gut microbiome and dysbiosis in health, disease, and healing” available NOW!

Authors: Natarajan Ranganathan, PhD, Usha Vyas and Kevin Hanlon


Read More
February 22, 2017

kibow-logo-hi-res_001On-demand Webinar | Free

It is well-known that unhealthy diet and sedentary lifestyle leads to obesity. With, globalization and adaptation of the Western-style (fast food) diet, obesity has become a global epidemic problem. In turn,

Read More
February 1, 2017


On-Demand Webinar | Free

In humans, the gastrointestinal tract represents a large microbial ecosystem, housing several trillion microbial cells. The human gut microbiome and its role in both health and disease has been researched

Read More